Revilab SL 06 for the Respiratory system
category: synthesized peptides
barcode: 4627099310818
packing: 0.33 fl.oz (10 ml)
Revilab SL06® a complex of reinforced peptides for the respiratory system.
It contains peptides of the T-link of the immune system, bronchi and lungs.
Preparations of the Revilab SL series are recommended to be used sublingually, so the active ingredients can directly enter the bloodstream, bypassing the digestive system and the primary transformation in the liver. The sublingual route of application is optimal for the use of highly active substances in low concentrations, including peptides. This delivery method is fast and economical.
Preparations from the Rēvilab SL series contain specially synthesized peptides and plant extracts that harmoniously combine with each other to eliminate the main causes of diseases and effectively prevent premature aging of the body.
This preparation is ideal for respiratory diseases, chronic bronchitis, lung inflammation, tonsillitis, runny nose, frequent colds, respiratory allergies, bronchial asthma, lung emphysema and other diseases.
FIELD OF APPLICATION:
- chronic bronchitis
- all types of tonsillitis
- pneumonia
- inflammation of the throat, angina
- respiratory allergy
- bronchial asthma
- lung emphysema
ACTIVE COMPONENTS:
peptide complexes of the B-link of the immune system AA-3, bronchi AA-14, lungs and stomach wall AA-15
extracts: licorice, propolis, mint; essential oils: chamomile, cloves, dihydroquercetin.
HOW TO USE AND DOSAGE:
The recommended standard dosage is 10 drops in the morning and evening,
regardless of the meal. Course duration 1 month.
Distributing over the oral mucosa, preferably under the tongue.
PACKING:
mini bottle, 0.33 fl.oz (10 ml) / product: Revilab SL-06 / Non-GMO. Not a medicinal product.
Apply 10 drops 2 times a day, morning and evening.
Distributing over the oral mucosa, preferably under the tongue.
A slight natural sediment is allowed, therefore, before application
it is recommended to shake the bottle.
The recommended duration of admission is 1-2 months.
If necessary, it is possible to re-take the drug during the year.